Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-21

Clinical Trial Update: A Study of Bezafibrate in Mitochondrial Myopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of bezafibrate in mitochondrial diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bezafibrate (bezafibrate)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Mitochondrial Diseases | Phase 2 | Status: COMPLETED